These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Adult final height after GH therapy for irradiation-induced GH deficiency in childhood survivors of brain tumors: the Belgian experience. Beckers D, Thomas M, Jamart J, Francois I, Maes M, Lebrethon MC, De Waele K, Tenoutasse S, De Schepper J. Eur J Endocrinol; 2010 Mar; 162(3):483-90. PubMed ID: 19969557 [Abstract] [Full Text] [Related]
27. Endocrine outcomes for children with embryonal brain tumors after risk-adapted craniospinal and conformal primary-site irradiation and high-dose chemotherapy with stem-cell rescue on the SJMB-96 trial. Laughton SJ, Merchant TE, Sklar CA, Kun LE, Fouladi M, Broniscer A, Morris EB, Sanders RP, Krasin MJ, Shelso J, Xiong Z, Wallace D, Gajjar A. J Clin Oncol; 2008 Mar 01; 26(7):1112-8. PubMed ID: 18309946 [Abstract] [Full Text] [Related]
31. Effects of cranial irradiation on hypothalamic-pituitary function--a 5-year longitudinal study in patients with nasopharyngeal carcinoma. Lam KS, Tse VK, Wang C, Yeung RT, Ho JH. Q J Med; 1991 Feb 01; 78(286):165-76. PubMed ID: 1851569 [Abstract] [Full Text] [Related]
33. Correlating measured radiotherapy dose with patterns of endocrinopathy: The importance of minimizing pituitary dose. Fraser O, Crowne E, Tacey M, Cramer R, Cameron A. Pediatr Blood Cancer; 2022 Nov 01; 69(11):e29847. PubMed ID: 35713216 [Abstract] [Full Text] [Related]